- Pain Products
- Cough, Cold and Flu Products
- Vitamins and Minerals
- Gastrointestinal Products
- Ophthalmic Products
- Sleep Aid Products
- Weight Loss/Diet Products
- Others
Latin America Over The Counter (OTC) Drugs Market was valued at USD 11.46 million in 2021 and is anticipated to grow at USD 17.34 million till 2028 recording a CAGR of 8.65% during the forecast period 2022-2028. Over-the-counter (OTC) drugs Market, also known as the non-prescription drugs that can be bought without a prescription. Over-the-counter drugs are safe and effective when the consumer follows the directions on the label or as provided by a physician. Over-the-counter (OTC) drugs are primarily used to treat conditions that do not require direct consultation of a doctor. Over-the-counter drugs provide affordable treatment and also help to decrease the workload of physicians. Over-the-counter drugs are easily available in pharmacies. Even though these products are considered as over-the-counter because these are not directly kept on pharmacy counters and must be dispensed by a pharmacist after confirming age, identity, and patient knowledge regarding usage of the product. Latin America over the counter drugs market is growing at a significant CAGR due to rise in the population. Increase in the adoption of western lifestyles, promotion and marketing initiatives for over-the-counter products, the rise in the healthcare expenditure, and an increase in the geriatric population expected to fuel the Latin America Over The Counter Drugs Market over the forecast period. Furthermore, rise in demand for self-medication with non-prescription drugs, changes in cultural attitudes regarding self-medications required for minor health problems, convenience in the direct purchase, savings enabled by the use of over-the-counter drugs, and developments and innovations in drugs products expected to fuel the Latin-America over-the-counter drugs market. However, competition between the existing market players, more possibilities of substance addiction and abuse, severity and complications involved in the taking of wrong medications due to misdiagnosis and lack of awareness among the rural population in developing and underdeveloped countries might hinder the Latin America over-the-counter drugs market over the forecast period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Latin America over the counter drugs market is growing at a significant CAGR due to rise in the population. Increase in the adoption of western lifestyles, promotion and marketing initiatives for over-the-counter products, the rise in the healthcare expenditure, and an increase in the geriatric population expected to fuel theLatin America Over The Counter Drugs Market over the forecast period. Furthermore, rise in demand for self-medication with non-prescription drugs, changes in cultural attitudes regarding self-medications required for minor health problems, convenience in the direct purchase, savings enabled by the use of over-the-counter drugs, and developments and innovations in drugs products expected to fuel the Latin-America over-the-counter drugs market. However, competition between the existing market players, more possibilities of substance addiction and abuse, severity and complications involved in the taking of wrong medications due to misdiagnosis and lack of awareness among the rural population in developing and underdeveloped countries might hinder the Latin America over-the-counter drugs market over the forecast period.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary |
2. Latin America Over The Counter (OTC) Market Introduction |
2.1. Latin America Over The Counter (OTC) Market – Taxonomy |
2.2. Latin America Over The Counter (OTC) Market –Definitions |
2.2.1. Product Type |
2.2.2. Formulation Type |
2.2.3. Distribution Channel |
3. Latin America Over The Counter (OTC) Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Latin America Over The Counter (OTC) Market Dynamics – Factors Impact Analysis |
3.6. Latin America Over The Counter (OTC) Market – Regulations |
3.7. Latin America Over The Counter (OTC) Market – Product Innovations |
4. Latin America Over The Counter (OTC) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Oppurtunity Analysis |
5. Latin America Over The Counter (OTC) Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 |
5.1. Pain Products |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.1.3. Market Opportunity Analysis |
5.2. Cough, Cold and Flu Products |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.2.3. Market Opportunity Analysis |
5.3. Vitamins and Minerals |
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.3.3. Market Opportunity Analysis |
5.4. Gastrointestinal Products |
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.4.3. Market Opportunity Analysis |
5.5. Ophthalmic Products |
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.5.3. Market Opportunity Analysis |
5.6. Sleep Aid Products |
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.6.3. Market Opportunity Analysis |
5.7. Weight Loss/Diet Products |
5.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.7.3. Market Opportunity Analysis |
5.8. Others |
5.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
5.8.3. Market Opportunity Analysis |
6. Latin America Over The Counter (OTC) Market Forecast, By Formulation Type, 2017 - 2021 and Forecast, 2022 - 2028 |
6.1. Tablets |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
6.1.3. Market Opportunity Analysis |
6.2. Liquids |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
6.2.3. Market Opportunity Analysis |
6.3. Ointments |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
6.3.3. Market Opportunity Analysis |
6.4. Sprays |
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
6.5.3. Market Opportunity Analysis |
7. Latin America Over The Counter (OTC) Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 |
7.1. Pharmacies |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
7.1.3. Market Opportunity Analysis |
7.2. Supermarkets/Hypermarkets |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
7.2.3. Market Opportunity Analysis |
7.3. Convenience stores |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
7.3.3. Market Opportunity Analysis |
7.4. Online drugstores |
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis |
7.5.3. Market Opportunity Analysis |
8. Argentina Over The Counter (OTC) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
8.1. Product Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Pain Products |
8.1.2. Cough, Cold and Flu Products |
8.1.3. Vitamins and Minerals |
8.1.4. Gastrointestinal Products |
8.1.5. Ophthalmic Products |
8.1.6. Sleep Aid Products |
8.1.7. Weight Loss/Diet Products |
8.1.8. Others |
8.2. Formulation Type Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Tablets |
8.2.2. Liquids |
8.2.3. Ointments |
8.2.4. Sprays |
8.2.5. Others |
8.3. Distribution Channel Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.3.1. Pharmacies |
8.3.2. Supermarkets/Hypermarkets |
8.3.3. Convenience stores |
8.3.4. Online drugstores |
8.3.5. Others |
8.4. Argentina Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2022 – 2028 |
8.5. Argentina Over The Counter (OTC) Market Dynamics – Trends |
9. Brazil Over The Counter (OTC) Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
9.1. Product Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Pain Products |
9.1.2. Cough, Cold and Flu Products |
9.1.3. Vitamins and Minerals |
9.1.4. Gastrointestinal Products |
9.1.5. Ophthalmic Products |
9.1.6. Sleep Aid Products |
9.1.7. Weight Loss/Diet Products |
9.1.8. Others |
9.2. Formulation Type Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Tablets |
9.2.2. Liquids |
9.2.3. Ointments |
9.2.4. Sprays |
9.2.5. Others |
9.3. Distribution Channel Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Pharmacies |
9.3.2. Supermarkets/Hypermarkets |
9.3.3. Convenience stores |
9.3.4. Online drugstores |
9.3.5. Others |
9.4. Brazil Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2022 – 2028 |
9.5. 9.4. Brazil Over The Counter (OTC) Market Dynamics – Trends |
10. Mexico Over The Counter (OTC) Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
10.1. Product Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Pain Products |
10.1.2. Cough, Cold and Flu Products |
10.1.3. Vitamins and Minerals |
10.1.4. Gastrointestinal Products |
10.1.5. Ophthalmic Products |
10.1.6. Sleep Aid Products |
10.1.7. Weight Loss/Diet Products |
10.1.8. Others |
10.2. Formulation Type Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Tablets |
10.2.2. Liquids |
10.2.3. Ointments |
10.2.4. Sprays |
10.2.5. Others |
10.3. Distribution Channel Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Pharmacies |
10.3.2. Supermarkets/Hypermarkets |
10.3.3. Convenience stores |
10.3.4. Online drugstores |
10.3.5. Others |
10.4. Mexico Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2022 – 2028 |
10.5. 9.4. Mexico Over The Counter (OTC) Market Dynamics – Trends |
11. Rest of Latin America Over The Counter (OTC) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
11.1. Product Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Pain Products |
11.1.2. Cough, Cold and Flu Products |
11.1.3. Vitamins and Minerals |
11.1.4. Gastrointestinal Products |
11.1.5. Ophthalmic Products |
11.1.6. Sleep Aid Products |
11.1.7. Weight Loss/Diet Products |
11.1.8. Others |
11.2. Formulation Type Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Tablets |
11.2.2. Liquids |
11.2.3. Ointments |
11.2.4. Sprays |
11.2.5. Others |
11.3. Distribution Channel Analysis 2017 – 2021 and Forecast, 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Pharmacies |
11.3.2. Supermarkets/Hypermarkets |
11.3.3. Convenience stores |
11.3.4. Online drugstores |
11.3.5. Others |
11.4. Rest of Latin America Over The Counter (OTC) Market - Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024 |
11.5. 9.4. Rest of Latin America Over The Counter (OTC) Market Dynamics – Trends |
12. Competition Landscape |
12.1. Strategic Dashboard of Top Market Players |
12.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
12.2.1. Novartis AG (Switzerland) |
12.2.2. Pfizer, Inc. (U.S.) |
12.2.3. Valeant (Canada) |
12.2.4. Perrigo Company plc. (U.S.) |
12.2.5. Sanofi (France) |
12.2.6. GlaxoSmithKline plc. (U.K.) |
12.2.7. Johnson & Johnson Services, Inc. (U.S.) |
12.2.8. Bayer AG (Germany) |
12.2.9. Takeda Pharmaceuticals company Ltd. (Japan) |
12.2.10. Teva Pharmaceutical Industries Ltd. (Israel) |
12.2.11. Bristol-Myers Squibb (U.S.) |
12.2.12. Reckitt Benckiser Group plc (U.K.) |
13. Research Methodology |
14. Key Assumptions and Acronyms |